Location Boston, Massachusetts, United States Regions Greater Boston Area, East Coast, New England Gender Male
LinkedIn View on LinkedIn
Brian Stuglik was appointed to Chief Executive Officer (CEO) of Verastem Oncology in July, 2019. Mr. Stuglik is a global leader in the oncology pharmaceutical sector with over 3 decades of experience in US and International pharmaceutical development, product strategy, commercialization and business development. He successfully developed, acquired
and launched several multi-billion dollar oncology brands across multiple tumor types and therapeutic approaches. Brian founded Proventus Health Solutions, a company specializing in helping oncology biotech companies create greater value by integrating development and commercial considerations into a unified approach. Currently, he serves as a member of the board of directors for Verastem Oncology (VSTM) and Oncopeptides AB (ONCO).
